<html>
<head>PUBMED IDs for SOX12</head>
<body bgcolor='#C5F0F2'><h1>SOX12</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16077994/'>Comparative genomics on SOX2 orthologs.</a> August 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/21124928/'>Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.</a> April 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21124921/'>TGF-β1 as possible link between loss of bone mineral density and chronic inflammation.</a> April 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21124918/'>Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.</a> April 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23466598/'>SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression.</a> August 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24019301/'>SOX12 and NRSN2 are candidate genes for 20p13 subtelomeric deletions associated with developmental delay.</a> October 23  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24920608/'>A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.</a> February 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26830765/'>SOXC Genes and the Control of Skeletogenesis.</a> December 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26998831/'>SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma.</a> February 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26998786/'>Non-mulberry silk fibroin grafted poly (Є-caprolactone)/nano hydroxyapatite nanofibrous scaffold for dual growth factor delivery to promote bone regeneration.</a> January 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27858992/'>SOX12: a novel potential target for acute myeloid leukaemia.</a> November 19  2016<br></body></html>
